Rapid Antigen Tests for Influenza: Rationale and Significance of the FDA Reclassification-Reference-Cited by-同舟云学术

Rapid Antigen Tests for Influenza: Rationale and Significance of the FDA Reclassification

Published:2018-10 Issue:10 Volume:56 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Green Daniel A.¹^ORCID,StGeorge Kirsten²³^ORCID

Affiliation:

1. Department of Pathology & Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York, USA

2. Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, USA

3. Department of Biomedical Science, University at Albany, SUNY, Albany, New York, USA

Abstract

Rapid antigen tests for influenza, here referred to as rapid influenza diagnostic tests (RIDTs), have been widely used for the diagnosis of influenza since their introduction in the 1990s due to their ease of use, rapid results, and suitability for point of care (POC) testing. However, issues related to the diagnostic sensitivity of these assays have been known for decades, and these issues gained greater attention following reports of their poor performance during the 2009 influenza A(H1N1) pandemic.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00711-18

Reference28 articles.

1. Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory Settings

2. National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events

3. Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients

4. Direct Detection of Influenza A and B Viruses in Less Than 20 Minutes Using a Commercially Available Rapid PCR Assay

5. Detection of influenza A and B with the Alere ™ i Influenza A & B: a novel isothermal nucleic acid amplification assay

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered nanoparticles for clinical assays;Nature Reviews Bioengineering;2024-07-08

2. At-home testing for respiratory viruses: a minireview of the current landscape;Journal of Clinical Microbiology;2024-05-08

3. Point of Care Molecular Testing;Clinics in Laboratory Medicine;2024-03

4. Lateral Flow Biosensor for On-Site Multiplex Detection of Viruses Based on One-Step Reverse Transcription and Strand Displacement Amplification;Biosensors;2024-02-17

5. Evaluation of Multiplex Rapid Antigen Test for the Detection of SARS-CoV-2 and Influenza A/B in Respiratory Samples;Clinical Laboratory;2024